default author photo

Ahmed Mohamed

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

85

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

FORTRESS-CART: Focused Observation and Risk Testing for Robust Evaluation of Safety in Chimeric Antigen Receptor T-cell Therapy (CAR-T): Real-World Predictors of Second Primary Malignancies (SPMs) Among Patients Treated with CAR-T

Number of pages: 39 Posted: 08 Sep 2025
Rafael Fonseca, Surbhi Sidana, Kevin C. De Braganca, Tamar Lengil, Ahmed Mohamed, Helen Pai, Matthew Perciavalle, Bruno Emond, Todd Bixby, Zaina P. Qureshi and Peter Voorhees
Mayo Clinic, Stanford Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Analysis Group, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 45 (1,121,190)

Abstract:

Loading...

CAR-T Cell Therapy, second primary malignancies, adverse events, Risk factors, Multiple myeloma, lymphoma, Leukemia

2.

Systematic literature review of secondary primary malignancies related to a CAR-T treatment in patients with multiple myeloma, lymphoma or leukemia

Number of pages: 20 Posted: 19 Nov 2025
Mounzer E. Agha, Sarah McGregor, Kevin C. De Braganca, Tamar Lengil, Victoria Alegria, Denise De Wiest, Matthew Perciavalle, Ravi Potluri, Sandip Ranjan, Callum Bannister, Ahmed Mohamed, Helen Pai, Todd Bixby, Zaina P. Qureshi and Peter Voorhees
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 40 (1,183,237)

Abstract:

Loading...

CAR-T therapy, Leukemia, Lymphoma, Multiple myeloma, Secondary primary malignancies